![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](ww6276contents.gif)
Acta Cryst. (2004). E60, o1851-o1853 [ doi:10.1107/S1600536804022366 ]
Abstract: The title compound, C10H11BO3, may be developed as a potent boron neutron capture therapy (BNCT) drug for hepatoma treatment. The compound was obtained as transparent rectangular plate crystals. Intermolecular hydrogen bonds and
-
interactions help stabilize the crystal structure.
Online 25 September 2004
Copyright © International Union of Crystallography
IUCr Webmaster